Skip to main content
https://pbs.twimg.com/media/Fn-9ACfWAAMzVQ0.jpg
Herpes Zoster with JAK Inhibitors A recent review a higher HZ risk with JAKi therapy shows the HZ-risk in RA and UC to be higher than PsA when treated with usual doses of TOFA, especially those given higher TOFA doses or concomitant glucocorticoids. https://t.co/BO7CgcuRKR https://t.co/gyMivn5YxL
Dr. John Cush
02-02-2023
×